VIDEO: How drug delivery has changed in AMD

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify cperla@healio.com if there are concerns regarding accuracy of the transcription.

So currently drugs are delivered via an intravitreal approach to treat wet macular degeneration. And that means we give the patients an injection essentially into the vitreous cavity of the eye. And these injections are given monthly or sometimes on a longer interval, if patients can, if their disease can tolerate that in order to get the medications delivered to the appropriate area of the eye. But as I discussed, there are delivery option changes that are coming down the pipeline with different drug depos, implants, and potentially also gene therapy.